[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339907-105":3,"doc-detail-339907-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-genetic-investigation-of-hereditary-breast-and-ovarian-cancer-patients-in-the-southern-transdanubian-region-widening-the-mutation-spectrum-and-searching-for-new-pathogenic-variants-using-next-generation-methods","Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region - widening the mutation spectrum and searching for new pathogenic variants using next-generation methods","","Retrospective genetic counselling and multigene panel testing were performed for 275 patients assessed for hereditary breast and ovarian cancer syndrome in the Southern Transdanubian region. Malignancy was present in 74.5% (205/275), while 25.5% (70/275) showed a positive family history of cancers, indicating genetic predisposition. Confirmed genetic variants occurred in 29.8% and 28.6% of these groups, with BRCA1/BRCA2 variants the most frequent cause (41.5%). A novel CDH1 mutation and double heterozygosity across susceptibility genes were identified, supporting genetic counselling and broader non-BRCA sequencing relevance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-genetic-investigation-of-hereditary-breast-and-ovarian-cancer-patients-in-the-southern-transdanubian-region-widening-the-mutation-spectrum-and-searching-for-new-pathogenic-variants-using-next-generation-methods/339907/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-genetic-investigation-of-hereditary-breast-and-ovarian-cancer-patients-in-the-southern-transdanubian-region-widening-the-mutation-spectrum-and-searching-for-new-pathogenic-variants-using-next-generation-methods/339907.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Who were included in the genetic analysis and how were patients selected?","Question",{"text":63,"@type":64},"The study retrospectively analyzed 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in the department.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What proportion of patients had malignancy versus only a family history?",{"text":68,"@type":64},"74.5% (205/275) were affected by some type of malignancy, while 25.5% (70/275) had a positive family history of different cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genes and variant findings were most important in the results?",{"text":72,"@type":64},"Variants were confirmed in 29.8% and 28.6% of the respective patient groups, with BRCA1/BRCA2 variants being the most common (41.5%). The study also detected a novel CDH1 mutation and cases of double heterozygosity across susceptibility genes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339907,1790456463,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd",8,"TYPE Original Research PUBLISHED 01 August 2024  \nDOI 10.3389/pore.2024.1611813  \nOPEN ACCESS  \nEDITED BY  \nJózsef Tímár,  \nSemmelweis University, Hungary  \n*CORRESPONDENCE  \nLászló Baráti,  \n [barati.laszlo@pte.hu](barati.laszlo@pte.hu)  \nRECEIVED 30 April 2024  \nACCEPTED 19 July 2024  \nPUBLISHED 01 August 2024  \nCITATION  \nBaráti L, Maász A, Mikó A, Bércesi É, Kalbani SA, Bene J, Kovács S, Mangel Land Hadzsiev K (2024), Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region:  \nwidening the mutation spectrum and searching for new pathogenic variants using next-generation methods. Pathol. Oncol. Res. 30:1611813 .  \ndoi: 10.3389/pore.2024.1611813  \nCOPYRIGHT  \n© 2024 Baráti, Maász, Mikó, Bércesi, Kalbani, Bene, Kovács, Mangel and Hadzsiev. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMolecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods  \nLászló Baráti 1*, Anita Maász 1, Alexandra Mikó 1,2, Éva Bércesi 3, Sultan Al Kalbani 1, Judit Bene 1, Sebestyén Kovács 4,  \nLászló Mangel 3 and Kinga Hadzsiev 1  \n1Department of Medical Genetics, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary, 2Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary, 3Department of Oncotherapy, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary, 4Urology Clinic, Clinical Centre, University of Pécs, Pécs, Hungary  \nHereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing have enabled medical professionals to determine whether a patient is harbouring mutations in moderate-or high penetrance susceptibility genes. We conducted a retrospective analysis among 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in our department. From these patients 74.5%(205/275) were affected by some type of malignancy, while the remaining 25.5%(70/275) had a positive family history of different cancers, suggesting a genetic predisposition. These tests conﬁrmed a genetic variant in 29 . 8% and 28. 6% of these patient groups respectively. The results also mirrored our general knowledge concerning the genetic background of hereditary breast and ovarian cancer, as variants in either one of the BRCA1 and BRCA2 genes proved to be the most common cause among our patients with 41 . 5% . Our test also detected a novel mutation in the CDH1 gene and three patients with double heterozygosity in two different susceptibility genes. This study demonstrates  \nPathology & Oncology Research 01 Published by Frontiers  \nthe relevance of genetic counselling and non-BRCA gene sequencing among cancer patients and patients who fulﬁl the criteria for genetic testing, while also providing important details about the genetic proﬁle of Hungarian patients.  \nKEYWORDS  \nHBOC, new generation sequencing, multigene panel testing, BRCA1, BRCA2  \nIntroduction  \nCancer is among the leading causes of mortality all over the world. Over the last decade, the incidence of malignancies has been growing worldwide, resulting in an estimated 20 million new cases and 9.7 million deaths in 2022. In most types of cancer, mortality has decreased due to preventive measures, im","cbCaiav3t4Kw82E8","https://ap.wps.com/l/cbCaiav3t4Kw82E8","pdf",668489,12,"English","# Introduction\n## Cancer burden and trends\n## Breast cancer in Hungary\n## Risk factors: modifiable vs non-modifiable\n## Genetic variants and inherited susceptibility\n## Hereditary cancer diagnosis progress","[{\"question\":\"Who were included in the genetic analysis and how were patients selected?\",\"answer\":\"The study retrospectively analyzed 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in the department.\"},{\"question\":\"What proportion of patients had malignancy versus only a family history?\",\"answer\":\"74.5% (205/275) were affected by some type of malignancy, while 25.5% (70/275) had a positive family history of different cancers.\"},{\"question\":\"Which genes and variant findings were most important in the results?\",\"answer\":\"Variants were confirmed in 29.8% and 28.6% of the respective patient groups, with BRCA1/BRCA2 variants being the most common (41.5%). The study also detected a novel CDH1 mutation and cases of double heterozygosity across susceptibility genes.\"}]","Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region - widening the mutation spectrum and searching for new pathogenic variants using next-generation methods | PDF",1790033033,30,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1a57a09810b24d54f8b07a246d6fa82.webp",983,1390,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/156e64c8afe7b72bfd00b5b9f52b7edb.webp",982,1388,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a9f3e024d1674a9976642789c17fce7.webp",981,1387,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88ae6bb7a87607e2ec5c0f72b2e59e79.webp",980,1385,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,147,152,155,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":98,"slug":146},"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":55,"slug":157},"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":131,"slug":161},19,"General","general"]